Treatment Foundations of Psychiatry & Behavioral Science

CPR APPLICATIONS FOUNDATION · CHAPTER 17 · TREATMENT

Treatment Foundations of Psychiatry & Behavioral Science

Organize the chapter before drilling into individual CPR concepts.

Supplemental foundation map: this page orients the detailed CPR Applications for Chapter 17. It is not part of the canonical CPR object inventory.

Browse the Foundations Library

Move through Chapter 17

Normal Foundations

Open normal foundations →

Abnormal Foundations

Open abnormal foundations →

Treatment Foundations · You are here

Open treatment foundations →

17.20 · SOURCE CPR FOUNDATION

Concept

Psychiatric treatment questions are decision-logic questions disguised as pharmacology, therapy, or safety questions. Step 1 often asks whether the treatment matches the symptom pattern, whether the medication is safe for the patient, or whether immediate risk overrides routine outpatient care. The core chain is mechanism → risk → next step.

Pattern

Step 1 tests antidepressants, antipsychotics, mood stabilizers, therapy modalities, suicide risk, involuntary hold criteria, capacity, confidentiality exceptions, and substance treatment. The safest immediate response often matters more than the ideal long-term plan.

Rule

  1. Match treatment to syndrome and risk. Medication, therapy, safety intervention, or reporting each has a different indication.
  2. Recognize adverse effects by mechanism. Receptor and organ-system toxicities often identify the drug.
  3. If acute safety is present, protect first. Suicide risk, violence risk, grave disability, abuse, and delirium require action.

Applications

  • SSRI plus linezolid hyperreflexia → serotonin syndrome
  • Antipsychotic fever rigidity CK elevation → NMS
  • Lithium polyuria tremor creatinine rise → toxicity concern
  • Suicidal ideation plan firearm → safety intervention
  • Reasonable suspicion of child abuse → follow applicable reporting laws and institutional safeguarding protocols; thresholds and processes vary by jurisdiction
  • Credible threat of serious harm toward an identifiable person → urgently assess safety and applicable jurisdiction-specific duties to protect, warn, or report
  • Tip: Safety overrides routine outpatient nuance

CPR APPLICATIONS · ACTIVE REASONING

Infer treatment toxicity from the affected pathway

Separate therapeutic target from toxicity. Identify the recent drug change, the neuromuscular pattern, and any organ-dependent clearance before choosing the mechanism. Select a response before checking the explanation. If scripting is unavailable, expand a worked answer. Responses are not stored or transmitted.

Decision 1: A patient taking an SSRI receives linezolid and rapidly develops agitation, diarrhea, inducible clonus, and hyperreflexia. What adverse syndrome is most concerning?

Reveal worked answer and transfer

Best answer: Serotonin syndrome related to serotonergic excess. Linezolid has monoamine oxidase-inhibiting properties, and clonus with hyperreflexia after serotonergic exposure supports serotonin syndrome.

Change one variable: How would lead-pipe rigidity after a dopamine-blocking drug change the differential?

Decision 2: After starting a dopamine receptor antagonist, a patient develops fever, severe generalized rigidity, autonomic instability, and elevated creatine kinase. What mechanism is a concern?

Reveal worked answer and transfer

Best answer: Neuroleptic malignant syndrome associated with dopamine antagonism. NMS is associated with dopamine blockade and a characteristic severe rigidity/hyperthermia syndrome.

Change one variable: How do clonus and hyperreflexia after a serotonergic medication distinguish a competing diagnosis?

Decision 3: A patient stable on lithium develops dehydration and starts a thiazide diuretic. What should be anticipated?

Reveal worked answer and transfer

Best answer: Reduced renal lithium clearance and increased toxicity risk. Thiazide-associated sodium handling changes and volume depletion can increase lithium reabsorption and serum exposure.

Change one variable: Which findings and laboratory measurements are relevant if tremor, ataxia, or confusion develops?

Change the mechanism

Review the comparison without scripts
  • Serotonergic agent interaction with clonus: Consider serotonin toxicity and urgent evaluation of interacting medications.
  • Dopamine antagonist with high fever and rigidity: Consider neuroleptic malignant syndrome requiring urgent medical assessment.
  • Lithium plus dehydration or thiazide: Toxicity risk increases; renal function and lithium level require evaluation.

Explain it back: For one decision, state the mechanism, a specific counterexample, and the finding that would change your conclusion.

Unscored educational practice; not psychometrically validated and not patient-specific medical advice.

How to use this foundation map

  1. Identify the organizing mechanism.
  2. Recognize the pattern.
  3. Restate the rule without looking.
  4. Test transfer with applications and question practice.

Pair CPR with the 5P Approach™ when solving cases and questions.